NÜMUNƏ ƏLIYEVA

Elmi dərəcə, ad soyad: Uzm. Dr. Nümunə Əliyeva
Tibbi bölmə: Daxili Xəstəliklər və Revmatologiya

Fəaliyyət İstiqamətləri:
• Revmatoid artrit, juvenil idiopatik artrit
• Osteoartrit
• Kristal artropatiler (gut, kalsiyum pirofosfat depolanma xəstəliyi və digərləri)
• Seronegativ spondiloartritlər (Ankilozan spondilit, psöriatik artrit, reaktiv artrit, enteropatik artrit)
• Sistemik Lupus Eritematozus, antifosfolipid sendrom
• Raynaud (Reyno) sendromu, sistemik skleroz (sklerodermiya), mikst birləşdirici toxuma xəstəliyi, differensiasiya olmamış birləşdirici toxuma xəstəliyi
• Dermatomyozit, polimyozit
• Sjögren sindromu (primer, sekonder)
• Fibromialgia
• Vaskülitlər 
• Ailəvi aralıq dənizi qızdırması, diğər otoinflamatuvar xəstəliklər• IgG4 əlaqəli xəstəlik
• Osteoporoz

Təhsil:

• Azərbaycan Tibb Universiteti Müalicə İşi və Profilaktika Fakultəsi 2005-2011
• İstanbul Tibb Fakültəsi Daxili Xəstəliklər Kafedrasında uzmanlıq təhsili 2013-2017
• İstanbul Tibb Fakültəsi Revmatologiya şöbəsinde yandal uzmanlıq təhsili 2018-2021

İş təcrübəsi:

• Liv Hospital Bonadea 
• Baku Medikal Plaza VIP
• Via Hospital Istanbul

Məqalə: 

• Sistemik Lupus Eritematozus ve Antifosfolipid Sendrom Tanılı Hastalarda Trombotik Riskin Değerlendirilmesine Yönelik Bileşik Tromboz Risk Skoru’nun Validasyonu ve Etkinliğinin aGAPSS (adjusted global antiphospholipid syndrome score) Skoru ile Karşılaştılması
• Sistemik Lupus Erıtematozusta Hastalık İlişkili Hasarın COVID-19 İnfeksiyonu Seyrine Olumsuz Etkileri
• Dermatomyozit hastalarında periferik vaskülopatinin tırnak dibi kapillaroskopisi ile değerlendirilmesi ve mikrosirkülasyondaki anormal bulguların tanımlanması
• İmmünsupresif Tedaviye Dirençli Sistemik Skleroz Hastalarında Rituksimab Tedavisi ile Hastalık Aktivitesi, Hastalık Şiddeti ve Hastalıkla İlişkili Hasar Bulgularının Seyri
• Skleroderma Renal Kriz: Tek Merkezde izlenen Sistemik Skleroz Hastalarında Sıklığı ve Klinik Özellikleri
• Ciddi Periferik Vasküler Hasra Nedeniyle Periferik Vazodilatatör Kullanan Sistemik Skleroz Hastalarının Klinik ve Tedavi Özellikleri
• Sıstemık Skleroz Hastalarında COVID-19 infeksiyonu Sıklığı ve Klinik Seyri: Tek Merkez Deneyimi
• Biyolojik Ajan Kullanan Ailevi Akdeniz Atesi Hastalarında COVID-19 Olumlu Seyri
• Kolşisine yetersiz yanıt nedeniyle anti IL-1 tedavi alan Ailevi Akdeniz Ateşi hastalarının retrospektif incelenmesi
• Criteria for the hyperinflammation developing in coronavirus disease-19: analysis of two cohorts from different periods of the pandemic
• The importance of parental consanguinity and family history of kidney disease in the Turkish adult chronic kidney disease population: An epidemiologic study

Nəşrlər:

• A Rare Clinical Entity: Staphylococcus-Related Glomerulonephritis (Exp Clin Transplant 2017 Mar 28. doi: 10.6002/ect.2016.0066)
• Effects of Rituximab on Atherosclerotic Biomarkers in Kidney Transplant Recipients (A Transplant Proc. 2019 May;51(4):1118-1120. doi:10.1016/j.transproceed.2019.01.106)
• Tümör nekrozis faktör-alfa inhibitörü tedavisi gereken aksiyel spondiloartritli hastalarda klinik özellikler ve tedavi sonuçları (Ulusal Romatoloji Dergisi / Journal of Turkish Society for Rheumatology • Cilt / Volume 13 • Sayı / Issue 3 • Aralık / December 2021)
• Genetic Screening of Early-Onset Patients with Systemic Lupus Erythematosus by A Targeted Next-Generation Sequencing Gene Panel (Lupus. 2022 Jan 27:9612033221076733. doi: 10.1177/09612033221076733)
• Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine (Journal of Medical Virology •21 March 2022 https://doi.org/10.1002/jmv.27731)
• Hakemli tibbi dergilerde yayinlanan ve uluslararasi kongrelerde poster sunumlar
• The Efficacy and Safety of Rituximab in 26 Cases of Treatment Resistant Systemic Sclerosis with Severe Disease Assessed by Activity Scores (6th Systemic Sclerosis World Congress HYPERLINK  "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" 2020) (P.321; Journal of Scleroderma and Related Disorders 2020, Vol. 5(1S) 1–307; https://doi.org/10.1177/2397198319898367 )
• The relationship Between Disease Activity and Severity in Systemic Sclerosis: A Prospective Analysis of 278 Patients (6th Systemic Sclerosis World Congress HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" 2020) (P.147; Journal of Scleroderma and Related Disorders 2020, Vol. 5(1S) 1–307; https://doi.org/10.1177/2397198319898367 )
• Evaluation of Different Classification Criteria in Systemic Sclerosis in a Turkish Cohort: The Importance of Non-Skin Manifestations, Serology and Capillaroscopy (6th HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/"Systemic Sclerosis World Congress HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" 2020) (P.148; Journal of Scleroderma and Related Disorders 2020, Vol. 5(1S) 1–307; https://doi.org/10.1177/2397198319898367
• The relationship Between Disease Activity and Severity in Systemic Sclerosis: A Prospective Analysis of 278 Patients (EULAR 2020) (THU0349; http://dx.doi.org/10.1136/annrheumdis-2020-eular.6129 )
• The Efficacy and Safety of Rituximab in 27 Cases of Treatment Resistant Systemic Sclerosis with Severe Disease Assessed by Activity Scores (EULAR 2020) (STAO346: http://dx.doi.org/10.1136/annrheumdis-2020-eular.6053)
• Evaluation of Different Classification Criteria in Systemic Sclerosis in a Turkish Cohort: The Importance of Non-Skin Manifestations, Serology and Capillaroscopy (EULAR 2020) (THU369; http://dx.doi.org/10.1136/annrheumdis-2020-eular.6000)
• Favourable Short-term Course of COVID-19 in Patients with Familial Mediterranean Fever Using Biologic Agents (EULAR 2021) (POS1259; http://dx.doi.org/10.1136/annrheumdis-2021-eular.3903)
• Systemic Sclerosis Associated Pulmonary Arterial Hypertension: Predominance of Pulmonary Fibrosis as a Risk Factor for Mortality in a Single Center Cohort (EULAR 2021) (ABO448; http://dx.doi.org/10.1136/annrheumdis-2021-eular.3460)
• Course of COVID-19 Infection in a Series of Patients with Systemic Lupus Erythematosus (EULAR 2021) (ABO653; http://dx.doi.org/10.1136/annrheumdis-2021-eular.368)
• Systemic Sclerosis Associated Pulmonary Hypertension: Predominance of Pulmonary Fibrosis as a Risk Factor for Mortality in a Single Center SSC-PH Cohort (7th Systemic Sclerosis World Congress; ID 255)
• Frequency and Clinical Characteristics of Scleroderma Renal Crisis from Turkey: Most Patients Do Not Have a Treatment History of High Dose Corticosteroids and ACE Inhibitors (7th Systemic Sclerosis World Congress; ID 260)
• COVID-19 Infections in Patients with Systemic Sclerosis: Factors Associated with Hospitalization (7 th Systemic Sclerosis World Congress; ID 260)

Üzvlüklər:

• Azərbaycan Revmatologiya Dərnəyi